0001367644-23-000179.txt : 20231005 0001367644-23-000179.hdr.sgml : 20231005 20231005191023 ACCESSION NUMBER: 0001367644-23-000179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231003 FILED AS OF DATE: 20231005 DATE AS OF CHANGE: 20231005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fowler Neal Franklin CENTRAL INDEX KEY: 0001493692 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 231312399 MAIL ADDRESS: STREET 1: C/O EMERGENT BIOSOLUTIONS INC. STREET 2: 400 PROFESSIONAL DR. STE. 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wk-form4_1696547413.xml FORM 4 X0508 4 2023-10-03 0 0001367644 Emergent BioSolutions Inc. EBS 0001493692 Fowler Neal Franklin 400 PROFESSIONAL DRIVE, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 0 Common Stock 2023-10-03 4 A 0 118670 0 A 118670 D Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. These restricted stock units will vest in three equal installments over a three-year period assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. /s/ Jennifer Lynn Fox, Attorney-in-fact 2023-10-05